nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC18A2—type 1 diabetes mellitus	0.61	0.711	CbGaD
Norepinephrine—ADRB1—type 1 diabetes mellitus	0.248	0.289	CbGaD
Norepinephrine—Isoetarine—ADRB1—type 1 diabetes mellitus	0.00117	0.223	CrCbGaD
Norepinephrine—Arbutamine—ADRB1—type 1 diabetes mellitus	0.000932	0.178	CrCbGaD
Norepinephrine—Salbutamol—ADRB1—type 1 diabetes mellitus	0.000905	0.172	CrCbGaD
Norepinephrine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.0006	0.143	CbGeAlD
Norepinephrine—Droxidopa—ADRB1—type 1 diabetes mellitus	0.000536	0.102	CrCbGaD
Norepinephrine—Isoprenaline—ADRB1—type 1 diabetes mellitus	0.000487	0.0928	CrCbGaD
Norepinephrine—PAH—kidney—type 1 diabetes mellitus	0.000426	0.102	CbGeAlD
Norepinephrine—Dopamine—ADRB1—type 1 diabetes mellitus	0.000419	0.0798	CrCbGaD
Norepinephrine—Epinephrine—ADRB1—type 1 diabetes mellitus	0.000409	0.0779	CrCbGaD
Norepinephrine—Epinephrine—TNF—type 1 diabetes mellitus	0.000388	0.0739	CrCbGaD
Norepinephrine—SLC6A2—nerve—type 1 diabetes mellitus	0.000338	0.0806	CbGeAlD
Norepinephrine—DRD2—nerve—type 1 diabetes mellitus	0.000308	0.0735	CbGeAlD
Norepinephrine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.000306	0.0731	CbGeAlD
Norepinephrine—SLC22A2—nephron tubule—type 1 diabetes mellitus	0.000228	0.0543	CbGeAlD
Norepinephrine—SLC22A2—kidney—type 1 diabetes mellitus	0.0002	0.0478	CbGeAlD
Norepinephrine—ADRA1B—kidney—type 1 diabetes mellitus	0.000192	0.0457	CbGeAlD
Norepinephrine—SLC22A1—kidney—type 1 diabetes mellitus	0.000141	0.0337	CbGeAlD
Norepinephrine—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.000139	0.0332	CbGeAlD
Norepinephrine—SLC22A3—kidney—type 1 diabetes mellitus	0.000135	0.0322	CbGeAlD
Norepinephrine—DRD2—retina—type 1 diabetes mellitus	0.000127	0.0304	CbGeAlD
Norepinephrine—SLC22A5—retina—type 1 diabetes mellitus	0.000119	0.0283	CbGeAlD
Norepinephrine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000117	0.0279	CbGeAlD
Norepinephrine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000116	0.0276	CbGeAlD
Norepinephrine—SLC22A5—nephron tubule—type 1 diabetes mellitus	0.000112	0.0267	CbGeAlD
Norepinephrine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.00011	0.0263	CbGeAlD
Norepinephrine—ADRA2C—kidney—type 1 diabetes mellitus	0.000103	0.0245	CbGeAlD
Norepinephrine—ADRA2C—pancreas—type 1 diabetes mellitus	0.000102	0.0243	CbGeAlD
Norepinephrine—SLC22A5—kidney—type 1 diabetes mellitus	9.82e-05	0.0234	CbGeAlD
Norepinephrine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	9.24e-05	0.0221	CbGeAlD
Norepinephrine—ADRA2A—pancreas—type 1 diabetes mellitus	8.13e-05	0.0194	CbGeAlD
Norepinephrine—ADRB3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.17e-05	8.78e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.16e-05	8.77e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.16e-05	8.75e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.16e-05	8.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GCG—type 1 diabetes mellitus	1.16e-05	8.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	1.16e-05	8.71e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.15e-05	8.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.15e-05	8.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	1.15e-05	8.62e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CAT—type 1 diabetes mellitus	1.14e-05	8.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CD86—type 1 diabetes mellitus	1.14e-05	8.58e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—NOS3—type 1 diabetes mellitus	1.14e-05	8.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.13e-05	8.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.12e-05	8.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.1e-05	8.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.1e-05	8.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.09e-05	8.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.08e-05	8.17e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.08e-05	8.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.08e-05	8.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.08e-05	8.14e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.08e-05	8.12e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.08e-05	8.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	1.07e-05	8.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.07e-05	8.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.07e-05	8.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.07e-05	8.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.07e-05	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.06e-05	7.97e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.06e-05	7.96e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.05e-05	7.94e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.04e-05	7.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	1.03e-05	7.76e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.03e-05	7.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	1.03e-05	7.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.03e-05	7.74e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	1.02e-05	7.7e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.02e-05	7.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.01e-05	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1e-05	7.54e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1e-05	7.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.98e-06	7.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.97e-06	7.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.96e-06	7.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.92e-06	7.47e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.92e-06	7.47e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.88e-06	7.44e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.86e-06	7.42e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.85e-06	7.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.83e-06	7.4e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.82e-06	7.4e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.76e-06	7.35e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.7e-06	7.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	9.69e-06	7.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.64e-06	7.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.63e-06	7.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CD86—type 1 diabetes mellitus	9.61e-06	7.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.61e-06	7.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	9.57e-06	7.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	9.46e-06	7.12e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.36e-06	7.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.28e-06	6.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.22e-06	6.94e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.21e-06	6.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.18e-06	6.91e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.16e-06	6.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.12e-06	6.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.12e-06	6.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.09e-06	6.85e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.08e-06	6.83e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.05e-06	6.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.03e-06	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.01e-06	6.78e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.01e-06	6.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.99e-06	6.77e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.98e-06	6.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.97e-06	6.76e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL2—type 1 diabetes mellitus	8.96e-06	6.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.95e-06	6.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.93e-06	6.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.92e-06	6.72e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.92e-06	6.72e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.88e-06	6.69e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.81e-06	6.63e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.76e-06	6.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.72e-06	6.57e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	8.72e-06	6.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.67e-06	6.53e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	8.64e-06	6.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.53e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.52e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	8.4e-06	6.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.4e-06	6.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.39e-06	6.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.34e-06	6.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.33e-06	6.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CD80—type 1 diabetes mellitus	8.31e-06	6.26e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.27e-06	6.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.27e-06	6.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.2e-06	6.18e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—INS—type 1 diabetes mellitus	8.14e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.14e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	8.13e-06	6.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.11e-06	6.1e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	8.08e-06	6.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.02e-06	6.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.97e-06	6e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	7.93e-06	5.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	7.92e-06	5.97e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.86e-06	5.92e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	7.85e-06	5.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	7.81e-06	5.88e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.73e-06	5.82e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.62e-06	5.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.6e-06	5.72e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—INS—type 1 diabetes mellitus	7.59e-06	5.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.58e-06	5.7e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.57e-06	5.7e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.56e-06	5.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.56e-06	5.69e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.54e-06	5.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	7.5e-06	5.65e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ALB—type 1 diabetes mellitus	7.47e-06	5.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.46e-06	5.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.45e-06	5.61e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	7.41e-06	5.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.41e-06	5.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.34e-06	5.53e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.31e-06	5.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.29e-06	5.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	7.26e-06	5.47e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	7.16e-06	5.39e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—NOS3—type 1 diabetes mellitus	7.14e-06	5.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	7.09e-06	5.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.04e-06	5.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.02e-06	5.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	7.01e-06	5.28e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	7e-06	5.27e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ALB—type 1 diabetes mellitus	6.96e-06	5.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	6.95e-06	5.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.92e-06	5.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.92e-06	5.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	6.9e-06	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.89e-06	5.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.89e-06	5.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.86e-06	5.17e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.86e-06	5.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.83e-06	5.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.82e-06	5.14e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.77e-06	5.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.77e-06	5.1e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.74e-06	5.07e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NOS3—type 1 diabetes mellitus	6.66e-06	5.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	6.62e-06	4.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	6.52e-06	4.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	6.43e-06	4.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.41e-06	4.82e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.39e-06	4.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.38e-06	4.8e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.36e-06	4.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.34e-06	4.77e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	6.32e-06	4.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.31e-06	4.75e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.28e-06	4.73e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.27e-06	4.72e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.25e-06	4.71e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.22e-06	4.68e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.14e-06	4.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.13e-06	4.61e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	6.01e-06	4.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.92e-06	4.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	5.9e-06	4.44e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.85e-06	4.4e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	5.84e-06	4.4e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.82e-06	4.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.81e-06	4.38e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.81e-06	4.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.81e-06	4.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.79e-06	4.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.78e-06	4.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.72e-06	4.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.69e-06	4.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	5.64e-06	4.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.6e-06	4.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.57e-06	4.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	5.38e-06	4.05e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.37e-06	4.04e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	5.35e-06	4.03e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.33e-06	4.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.32e-06	4.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.29e-06	3.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.28e-06	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.27e-06	3.97e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.27e-06	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—type 1 diabetes mellitus	5.27e-06	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.25e-06	3.95e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.21e-06	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.2e-06	3.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.2e-06	3.92e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.18e-06	3.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.18e-06	3.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.17e-06	3.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.08e-06	3.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.93e-06	3.71e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.92e-06	3.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.91e-06	3.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.9e-06	3.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.85e-06	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.85e-06	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.82e-06	3.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.81e-06	3.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.72e-06	3.55e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.48e-06	3.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.47e-06	3.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.47e-06	3.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.47e-06	3.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.45e-06	3.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.44e-06	3.34e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.38e-06	3.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.31e-06	3.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.3e-06	3.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.28e-06	3.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.14e-06	3.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.08e-06	3.07e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.07e-06	3.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.03e-06	3.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.01e-06	3.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	4e-06	3.01e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.98e-06	3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.98e-06	3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.77e-06	2.84e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.76e-06	2.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.71e-06	2.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.62e-06	2.73e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.55e-06	2.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	3.43e-06	2.58e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.42e-06	2.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.37e-06	2.53e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.29e-06	2.48e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	3.26e-06	2.45e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.13e-06	2.35e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.11e-06	2.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.1e-06	2.33e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.06e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.06e-06	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.89e-06	2.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.85e-06	2.15e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.63e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.53e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.35e-06	1.77e-05	CbGpPWpGaD
